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Sleep deprivation increases the risk of recurrent seizures in epileptic patients. We identified 10 patients with 
recurrent seizures and sleep disruption related to obstructive sleep apnoea. Two patients were treated with 
positional therapy and the remaining eight patients were treated with continuous positive airway pressure. Three of 
the patients became seizure free and a fourth patient had a greater than 95% reduction in seizure frequency 
following only the initiation of therapy for the sleep apnoea. Three of these four patients responding to therapy, 
had a state-dependent seizure pattern. Two of the four responders did not exhibit the typical body habitus for 
obstructive steep apnoea. Three additional patients improved in seizure frequency with change in anticonvulsant 
medication and treatment of the obstructive sleep apnoea. The remaining three patients had less than 50% 
reduction in seizure frequency with treatment of the obstructive sleep apnoea. These results indicate sleep 
disruption caused by sleep apnoea may increase the seizure frequency in some epileptic patients. Regardless of 
body habitus, epilepsy patients hould be questioned carefully for a history of sleep disturbance and state 
dependence to their seizures. Treatment of sleep disorders in this population may lower the frequency of recurrent 
seizures. 
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INTRODUCTION 
Sleep has long been known to affect epilepsy. In 
1881, Gower studied the relationship of 
sleep/awake state to epilepsy, noting that 21% of 
patients had seizures solely during sleep ~. He 
noted that other patients had seizures only during 
the awake state (42%) while a third group had 
seizures during both the awake and asleep states 
(37%). Later investigation, by Janz, revealed that 
some individuals have seizures primarily in the 
first two hours after awakening. Janz coinedthe 
term 'awakening' epilepsies for these individuals, 
and referred to seizures occurring without depen- 
dence on the sleep/awake state as diffuse 
epilepsies 2"3. The sleep-related epilepsies and the 
awakening epilepsies can be grouped into state- 
dependent epilepsies and the diffuse epilepsies as 
a state independent epilepsies. 
Sleep deprivation may exacerbate seizures in 
some patients with epilepsy 4-7. Sleep deprivation 
This paper was previously presented in part at the American 
Epilepsy Society Meeting in December of 1993. 
is frequently used in long-term epilepsy monitor- 
ing settings to promote seizures, and may also 
uncover interictal abnormalities on electroen- 
cephaiographic (EEG) recordings 4. This activa- 
tion of interictal activity may be related to the 
promotion of the onset of sleep 8, but this point 
has yet to be resolved. Sleep may activate 
interictal activity in approximately one third of 
epileptic patients and up to 90% of subjects with 
sleep-wake related, or state dependent, 
epilepsies S.9-11" 
Obstructive sleep apnoea (OSA) disrupts leep 
and can cause severe sleep deprivation. In one 
population study, as high as 6% of males between 
35 and 65 years old had OSA at night lz. 
Neurological manifestations of OSA include 
cognitive decline and autonomic symptoms. 
However, seizures as a direct result of apnoea 
are rare. In one patient, an apnoea in sleep 
reportedly cause a seizure after severe oxygen 
desaturation and cardiac arrest ~3. In another 
patient who had epilepsy, Wyler reported 
some improvement in seizure intensity with 
treatment of sleep apnoea '4. Since our initial 
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presentation a subsequent report of treatment of 
sleep apnoea on epilepsy demonstrated similar 
results 15"~6. Considering these factors, we re- 
viewed our patient population for patients with 
both OSA and epilepsy to examine the effect of 
treatment of OSA on seizure frequency. 
METHODS 
We sequentially identified 10 adult epileptic 
subjects with OSA who were seen in the 
University of North Carolina Epilepsy Clinic 
between January 1991 and April 1993. The 
diagnosis of epilepsy and seizure type was 
determined by an epileptologist, on the basis of 
historical and laboratory data. Seizure frequency 
on pretreatment regimen was determined by 
history and seizure calendars prior to the start of 
therapy for sleep apnoea. 
The diagnosis of OSA was determined on the 
basis of clinical history and overnight polysomno- 
grams. Overnight polysomnograms were per- 
formed recording electro-oculogram, EEG, sub- 
mental electromyogram, surface electromyogram 
from left and right anterior tibialis, electrocardio- 
gram (ECG), nasal/oral air temperature, con- 
tinuous carbon dioxide monitoring from the nose, 
chest movement, abdominal movement and oxy- 
gen saturation from the index finger. Four 
patients had oesophageal pressure monitoring 
during the study. The records were scored using 
Rechtschaffen a d Kales criteria tT. Apnoeas were 
determined as an absence of air flow, by 
monitoring device output, for 10 seconds or 
greater. Apnoeas were characterized asobstruc- 
tive if chest or abdominal movement continued 
during the event. Hyponoeas were determined by 
a greater than 50% decrease without absence of 
airflow in air flow measures for 10 seconds or 
greater. The respiratory disturbance index (RDI) 
was calculated as the number of apnoeas plus 
hyponoeas per hour. Patients were determined to
have sleep apnoea if the respiratory disturbance 
index was greater than 10 events per hour. 
Continuous positive airway pressure (CPAP) was 
initiated during the first night of study if the 
patients exhibited prolonged apnoeas with heart 
rate less than 55 beats per minute and oxygen 
desaturation below 75% in the first two hours of 
the polysomnogram. Patients who did not exhibit 
this severity were observed for the remainder of 
the night and had a CPAP trial on a second night 
if the apnoea was not related to position. CPAP 
was titrated to the normalization of the patient's 
respiration in the supine position during REM 
sleep and to maintain oxygen saturation above 
90%. The patients were subsequently treated as 
outpatients for their OSA with either positional 
therapy or CPAP based on the overnight 
polysomnogram. Each patient's seizure frequency 
and anticonvulsant regimen were followed for at 
least one year following the institution of therapy. 
Seizure frequency was calculated by patient 
report on seizure calendars. Anticonvulsant levels 
were obtained before and following the institu- 
tion of therapy for the OSA. 
Correlation statistics were performed using 
Pearson Product-Moment correlation with sig- 
nificance determined as a P value of less than 
0.05. 
RESULTS 
The subjects ranged in age from 21 to 79 years. 
Only one of the subjects was female. One patient 
had a primary generalized epilepsy and the 
remaining patients had partial seizures. Nine of 
the subjects were referred for evaluation and 
therapy of a known seizure disorder. The 
remaining subject was referred for a evaluation of 
unusual nocturnal spells and was subsequently 
diagnosed with epilepsy. 
All the subjects noted snoring and symptoms of 
excessive daytime sleepiness or unrefreshing 
sleep. Only one patient was referred with a 
known diagnosis of OSA. None of the subjects 
had craniofacial abnormalities such as microg- 
nathia or retrognathia, or hypothyroidism which 
would contribute to airway obstruction. A wide 
variety of sleep stages percentages and latencies 
were found among the patients (Table 1). Three 
patients (Patients 1, 2 and 10) had CPAP initiated 
on the first night of study due to bradycardia or 
severe oxygen desaturations associated with 
apnoeas (Table 1). 
Four of the patients improved with treatment 
of the sleep apnoea lone. Three of these patients 
(Patients 2, 3 and 4) became seizure free and a 
fourth patient (Patient 1) had a greater than 95% 
reduction in seizure frequency following the 
initiation of therapy for the sleep apnoea without 
any change to the anticonvuisant regimen. Three 
of these four patients, had a state dependent 
seizure pattern (Patient 1, awakening and Pati- 
ents 3 and 4, sleep related). Three patients of this 
group had partial seizures ranging in frequency of 
two per year to three per month. The remaining 
patient had daily bouts of myoclonic seizures. 
These four responders anged from mild to severe 
OSA. Two of the four responders exhibited the 
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Table 1: Sleep stage parameters from the diagnostic sleep study from ten patients. 
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Patient Sleep Total Sleep REM Awake Stage 1 
number efficiency (%) sleep latency latency (%) (%) 
time (minutes) (minutes) 
(minutes) 
Stage 2 Stage REM CPAP 
(%) 3&4 (%) (%) started on 
first 
night 
1 72 305 45 112 16 13 
2 87 351 1 121 12.5 17 
3 55 237 36.5 52 39 5 
4 71 280 5 243 28 9 
5 98 354 2 243 2 14 
6 73.5 322 28 390 19 63 
7 90 355 4 144 8 11 
8 95 69 I 249 1 12 
9 65.5 272 36.5 183 27 19 
10 64 261 17.5 287 30 8 
16 31 22 Yes 
28 24 18 Yes 
31 18 7 No 
44 13 7 No 
54 25 5 No 
13 3 1 No 
55 18 8 No 
50 27 7 No 
22 27 4 No 
24 32 5 Yes 
REM, Rapid eye movement sleep. 
typical body habitus for OSA. The other two 
responders (Patients 3 and 4) weighed under 200 
pounds and did not exhibit any physical features 
suggesting upper airway obstruction. These 
patients were treated with positional therapy 
based on significant improvement of the OSA 
observed with the patients assuming the lateral 
decubitus position (Table 2). 
Three patients improved with medication 
change and treatment of the OSA. Patient 5, who 
was on valproate, had phenobarbital dded as a 
second medication, one month prior to the 
institution of CPAP. His seizure frequency went 
from an average of four seizures per month for 
the year to two seizures the month prior to 
CPAP. This patient improved further following 
treatment of OSA having had only one seizure in 
the year since the initiation of CPAP. Patient 6 
had an increase in phenobarbital one month prior 
to the institution of the CPAP. This patient's last 
seizure occurred three weeks prior to starting 
CPAP, and he has been seizure-free for 14 
months. The third patient (Patient 7) was 
averaging one seizure per three months, prior to 
the treatment of the OSA. This patient had one 
seizure six months following the initiation of 
CPAP and subsequently started anticonvulsant 
therapy. This patient has since been seizure-free 
for one year. 
Three patients (Patients 8, 9 and 10) had less 
than a 50% reduction in seizure frequency. All 
three of these patients had state independent 
pattern to their seizures. One of the non- 
responders (Patient 9) tried CPAP, but was 
unable to tolerate this therapy after two months. 
The patient's overnight polysomnogram demons- 
trated some improvement but not total resolution 
of the sleep apnoea with the patient in the lateral 
decubitus position. We opted for positional 
therapy as an alterantive treatment for this 
patient, knowing that the lateral decubitus 
position did not totally resolve the OSA. The 
patient also lost 62 pounds but neither of these 
manoeuvres were associated with improvement in 
seizure frequency. However, this patient did have 
subjective benefit in daytime sleepiness and 
declined further objective testing. 
Review of sleep parameters compared to 
seizure improvement revealed the seizure percent 
improvement of the seizure frequency did not 
correlate with the RDI ( r=-0.23)  or sleep 
efficiency (r=0.10) even with removing the 
patients who received CPAP the first night. 
DISCUSSION 
Sleep disruption or oxygen desaturation from 
OSA could exacerbate an underlying seizure 
disorder. Improvements in sleep quality will 
decrease seizure frequency in some patients'". 
Four of our patients (40%) reduced the frequency 
of recurrent seizures olely with the treatment of 
the OSA and an additional three patients 
improved with adjustments of anticonvulsant 
medication combined with treatment of their 
OSA. This improvement may have resulted from 
avoiding severe oxygen desaturation at night or 
the improved sleep quality by the elimination of 
the periodic arousals evoked by the obstructive 
apnoeas. However, neither the severity of apnoea 
nor the type of treatment for OSA appeared to be 
a consistent factor amongst the group of 
responders. 
In our series, the lack of severe oxygen 
desaturation i many of these patients uggests 
the oxygen desaturation is not the principal factor 
in exacerbating the seizures. Four of our patients 
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did not have oxygen desaturation below 80%. 
The desaturation i  these cases clearly can not 
account for the recurrence of seizures unless the 
patients had more severe nocturnal oxygen 
desaturations than recorded. This is possible but 
is improbable, particularly in the patients with 
relatively thin body habitus, since these patients 
have adequate pulmonary functional reserve 
capacity. 
Sleep disruption and sleep deprivation may be 
factors in exacerbating seizures in these patients. 
Sleep disruption would also lead to increased 
sleep/wake transitions which may in itself in- 
crease the likelihood of seizures. Sleep disruption 
related to the sleep apnoea may be estimated by 
the RDI. Percent improvement of the seizure 
frequency did not correlate with the RDI or sleep 
efficiency. This may indicate that any disruption 
of sleep or increase in sleep wake transitions 
greater than a certain level might exacerbate the 
underlying seizure disorder in specific epileptic 
patients. 
Although obesity is a common feature in 
patients with symptoms of OSA, two of the 
patients, who improved with treatment of their 
sleep apnoea, were not obese. Patients exhibiting 
normal body habitus have been found to have 
OSA, and a more subtle form of night-time 
airway obstruction, upper airway resistance 
syndrome ~9. Upper airway resistance syndrome 
can produce similar daytime sequelae as OSA. 
Many types of epilepsy increase sleep 
disturbance 2°. These are usually marked by 
increase number of stage changes and arousals. 
Epilepsy, however, has not been reported to 
increase the risk of OSA, but large population 
studies have not been performed to adequately 
assess the prevalence of OSA in epileptic 
patients. 
Medications may have an affect upon sleep 
apnoea. Similar to benzodiazepines and alcohol, 
barbiturates decrease the tone of upper airway 
muscles and thus increase upper airway obstruc- 
tion during sleep 21. Three patients were pre- 
scribed phenobarbital nd two of these patients 
improved with the addition of CPAP and 
medication adjustment. Valproate may also ex- 
acerbate a tendency for OSA by the enhancing 
weight gain. However, only one patient of three 
on valproate (Patient 9), noted any weight gain 
with the medication and this patient did not 
improve in seizure frequency once treated for the 
OSA. 
In general, seizures in patients with state 
dependent types of epilepsy are more likely to 
respond to anticonvulsant therapies than those 
with a state independent epilepsy, as reported by 
Janz 3. Three of the four patients, who improved 
with only treatment of the OSA, had epilepsy 
which was dependent upon the sleep or awake 
state. One of the three patients, who improved 
with adjustment to medication and treatment of 
the OSA, had a state-dependent pattern of 
epilepsy. Forty percent of our study population 
had a state-dependent pattern to their seizures 
and this may have skewed our results. Yet, three 
of the patients who improved (one with CPAP 
alone, two with CPAP and medication) had state 
independent patterns of epilepsy. Conversely, all 
of the non-responding epileptic patients had a 
state-independent pattern to their epilepsy. The 
lack of state dependence of their seizures may 
indicate their loci are less influenced by the 
environmental changes produced by sleep and 
sleep disorders. In this context, one .would predict 
that patients with state independent epilepsy 
would be less likely to improve in seizure 
frequency following improvement in sleep 
quality. 
Regardless of the mechanism, we feel OSA 
should be considered as a possible exacerbating 
factor in patients with epilepsy. All epilepsy 
patients, despite body habitus, should be ques- 
tioned for symptoms of OSA or other forms of 
sleep disturbance. The possibility of sleep distur- 
bance should not be overlooked, particularly in 
patients failing to respond to treatment. Evalua- 
tion and treatment of epileptic patients with OSA 
should be pursued to improve the frequency of 
recurrent seizures and the symptoms directly 
attributable to the OSA. 
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